Latest 10-Q quarterly reports
NASDAQ
Patterson-UTI Energy, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a net loss and detailing its strategic exit from Colombian contract drilling operations.
NYSE
Innovex International, Inc. announced its second quarter 2026 financial results, showcasing a 9% increase in total revenues driven by strong performance in the NAM market and strategic acquisitions, despite a substantial legal settlement impacting net income.
NASDAQ
FRSH
Freshworks INCFreshworks Inc. announced its second-quarter 2026 financial results, showcasing a 16% year-over-year increase in total revenue to $237.4 million, alongside a return to operating income.
NYSE
Innovative Industrial Properties, Inc. reported stable rental revenues in Q2 2026, alongside significant new debt issuance and continued investment in life sciences, while navigating tenant defaults.
NYSE
Public Service Enterprise Group (PSEG) and its subsidiary PSE&G reported their Q2 2026 financial results, showing stable performance in regulated operations despite market-driven fluctuations impacting PSEG Power.
NASDAQ
DGICA
Donegal Group INCDonegal Group Inc. announced its second quarter 2026 financial results, showcasing a significant increase in net income and improved underwriting profitability.
NASDAQ
Kratos Defense & Security Solutions, Inc. announced a substantial increase in revenues and backlog, driven by strategic acquisitions and robust demand in its defense and security segments.
NYSE
EOG Resources announced a significant increase in operating revenues and net income for the second quarter of 2026, driven by higher commodity prices and increased production volumes.
NYSE
TrueBlue, Inc. reported a net loss of $3.4 million for the thirteen weeks ended June 28, 2026, despite an 11.8% increase in revenue to $443.0 million, impacted by lower gross profit margins and a goodwill impairment charge.
NASDAQ
IPAR
Interparfums INCInterparfums, Inc. announced its Q2 2026 financial results, showcasing a 2% increase in net sales driven by strong performance in North America and key brands, despite ongoing geopolitical impacts.
NASDAQ
Limbach Holdings reported a 21.9% increase in Q2 revenue driven by acquisitions, but saw a 6.4% decrease in gross profit and a significant drop in net income compared to the prior year.
NASDAQ
IPG Photonics Corporation announced its second quarter 2026 financial results, showing an 11.1% increase in net sales to $278.6 million, driven by strong performance in Industrial Solutions.
NASDAQ
UONE
Urban One, INCUrban One, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a 6.4% decrease in net revenue and significant impairment charges, while also detailing strategic acquisitions and debt management.
NYSE
Bio-Rad Laboratories' Q2 2026 report shows flat net sales, with a decline in Life Science offset by modest growth in Clinical Diagnostics, while managing significant market uncertainties and a substantial investment portfolio.
NASDAQ
Rocky Brands Inc. announced a significant increase in net sales and gross margin for the second quarter of 2026, driven by strong performance across all segments and favorable tariff refund recognition.
NYSE
Fifth Third Bancorp announced significant revenue growth and improved net interest margin in Q2 2026, largely driven by the successful integration of the Comerica acquisition.
NYSE
APTV
Aptiv PLCAptiv PLC's Q2 2026 filing shows increased net sales and operating income, driven by volume growth, alongside significant strategic activities including a business spin-off and debt management.
NYSE
ONEOK, Inc. announced significant revenue and operating income increases for the second quarter of 2026, driven by higher volumes and optimization activities across its key business segments.
NYSE
Community Healthcare Trust Inc. (CHCT) announced its second-quarter 2026 financial results, showcasing increased rental income and a return to profitability, alongside strategic property acquisitions.
NYSE
Turning Point Brands reported a 22.6% increase in net sales for Q2 2026, driven by its Stokers segment, but saw a significant drop in net income attributable to the company due to higher operating expenses.
NASDAQ
Cyclerion Therapeutics' Q2 2026 10-Q filing reveals substantial doubt about its ability to continue as a going concern, alongside details of a proposed merger with Korsana Biosciences.
NYSE
Live Oak Bancshares announced a significant increase in net income attributable to common shareholders for the second quarter of 2026, driven by higher net interest income and a lower provision for credit losses.
VRMMQ
Vroom, INCVroom, Inc. reports on its financial condition and operational performance, highlighting efforts to manage credit losses and secure future capital following a Chapter 11 emergence.
NASDAQ
SIBN
Si-bone, INCSI-BONE, Inc. announced a 15.2% increase in revenue for the second quarter of 2026, driven by strong procedural volume growth in the U.S. and expanding international sales.
NYSE
Jacobs Solutions Inc. announced its third quarter fiscal year 2026 results, with revenues increasing by 34.5% year-over-year, driven by strong performance in its Infrastructure & Advanced Facilities segment.
NYSE
IBTA
Ibotta, INCIbotta's Q2 2026 filing reveals a net loss and a decline in direct-to-consumer redemptions, though third-party publisher redemptions show significant growth.
NASDAQ
PSNL
Personalis, INCPersonalis, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing a 30% revenue increase driven by clinical diagnostic growth, but also reporting substantial net losses and ongoing operational risks, all while navigating a pending acquisition by Tempus AI.
NYSE
Mercury General Corporation's Q2 2026 results show a substantial increase in net income and improved underwriting performance, driven by premium growth and effective cost management.
NYSE
Alaska Air Group reported a net loss of $76 million for the second quarter of 2026, impacted by a substantial increase in aircraft fuel expenses and ongoing integration costs.
NASDAQ
OnKure Therapeutics, Inc. filed its Form 10-Q for the period ending June 30, 2026, detailing financial performance, ongoing R&D, and a significant private placement.